Assured Investment Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-32,171
Closed -$578K 523
2019
Q1
$578K Buy
32,171
+8,801
+38% +$152K 0.01% 543
2018
Q4
$297K Buy
23,370
+366
+2% +$6.14K 0.01% 798
2018
Q3
$493K Sell
23,004
-12,465
-35% -$266K 0.01% 769
2018
Q2
$732K Buy
35,469
+35,055
+8,467% +$790K 0.01% 681
2018
Q1
$10K Buy
+414
New +$10.1K ﹤0.01% 1132

Other funds holding MGNX

Assured Investment Management's MGNX Position: Q2 2019 in Review

Assured Investment Management sold out of MacroGenics (MGNX) in Q2 2019, closing a stake of 32,171 shares — an estimated $578K sold.

Assured Investment Management first reported a position in MGNX in Q1 2018 and held it in 5 quarters. The position peaked at $732K in Q2 2018. 130 funds tracked by Wall St. Rank hold MGNX as of Q2 2019.

  • Assured Investment Management reported no remaining MacroGenics position as of Q2 2019 after selling out during the quarter.
  • Assured Investment Management sold 32,171 MacroGenics shares in Q2 2019, an estimated $578K.
  • Assured Investment Management first reported a position in MacroGenics in Q1 2018 and held it in 5 quarters.
  • Assured Investment Management's MacroGenics position peaked at $732K in Q2 2018.
  • 130 funds tracked by Wall St. Rank held MacroGenics as of Q2 2019.

Based on Assured Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.